[The cardiovascular effects of neuroleptics based on current knowledge].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001341:Autonomic Nervous System / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use; D002749:Chlorprothixene / Q000009:adverse effects / Q000627:therapeutic use; D003645:Death, Sudden; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008297:Male; D008653:Mesoridazine / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D010640:Phenothiazines / Q000009:adverse effects; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use
D010640:Phenothiazines; D014149:Tranquilizing Agents; D008653:Mesoridazine; D002749:Chlorprothixene; D002746:Chlorpromazine
Die kardiovasculären Wirkungen der Neuroleptika nach dem heutigen Erkenntnisstand.